Compounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants.

Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. (1/35)

Antisense oligonucleotides against the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are able to reduce some forms of apoptosis. In those forms, overall GAPDH levels increase and the enzyme accumulates in the nucleus. The monoamine oxidase B (MAO-B) inhibitor, (-)-deprenyl (DEP), its metabolite (-)-desmethyldeprenyl, and a tricyclic DEP analog, CGP3466, can reduce apoptosis independently of MAO-B inhibition and have been found to bind to GAPDH. We used neuronally differentiated PC12 cells to show that DEP, DES, and CGP3466 reduce apoptosis caused by serum and nerve growth factor withdrawal over the concentration range of 10(-) to 10(-13) M. We provide evidence that the DEP-like compounds bind to GAPDH in the PC12 cells and that they prevent both the apoptotic increases in GAPDH levels and nuclear accumulation of GAPDH. In vitro, the compounds enhanced the conversion of NAD(+) to NADH by GAPDH in the presence of AUUUA-rich RNA and converted GAPDH from its usual tetrameric form to a dimeric form. Using cell lysates, we found a marked increase in rates of NAD(+) to NADH conversion in early apoptosis, which was returned toward control values by the DEP-like compounds. Accordingly, the DEP-like compounds appear to decrease glycolysis by preventing the GAPDH increases in early apoptosis. GAPDH dimer may not have the capacity to contribute to apoptosis in a similar manner to the tetramer, which might account for the antiapoptotic capacity of the compounds. These actions on GAPDH, rather than MAO-B inhibition, may contribute to the improvements in Parkinson's and Huntington's diseases found with DEP treatment.  (+info)

Haematocin, a new antifungal diketopiperazine produced by Nectria haematococca Berk. et Br. (880701a-1) causing nectria blight disease on ornamental plants. (2/35)

A new antifungal diketopiperazine named haematocin was isolated from the culture broth of Nectria haematococca Berk. et Br. (880701a-1) causing blight disease on ornamental plants, Phalaenopsis spp. and Doritanopsis spp. Its structure was established by spectroscopic methods. Haematocin inhibited the germ-tube elongation and spore-germination of Pyricularia oryzae at the ED50 values of 30 microg/ml and 160 microg/ml, respectively.  (+info)

An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease. (3/35)

Apoptosis and mitochondrial dysfunction are thought to be involved in the aetiology of neurodegenerative diseases. We have tested an orally active anti-apoptotic molecule (CGP 3466B) that binds to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in an animal model with motoneuron degeneration, i.e. a mouse mutant with progressive motor neuronopathy (pmn). In pmn/pmn mice, CGP 3466B was administered orally (10 - 100 nmol kg(-1)) at the onset of the clinical symptoms (2 weeks after birth). CGP 3466B slowed disease progression as determined by a 57% increase in life-span, preservation of body weight and motor performance. This improvement was accompanied by a decreased loss of motoneurons and motoneuron fibres as well as an increase in retrograde transport. Electron microscopic analysis showed that CGP 3466B protects mitochondria which appear to be selectively disrupted in the motoneurons of pmn/pmn mice. The data support evaluation of CGP 3466B as a potential treatment for motor neuron disease.  (+info)

Synthesis of 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo-[b,f]furo[2,3-d]oxepin derivatives as potential anxiolytic agents. (4/35)

New synthesis approaches that have led to a series of novel tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives are described. According to preliminary data these novel tetracycles can be useful intermediates for the preparation of potential new therapeutic agents.  (+info)

Early alcohol exposure induces persistent alteration of cortical columnar organization and reduced orientation selectivity in the visual cortex. (5/35)

Fetal alcohol syndrome (FAS) is a major cause of learning and sensory deficits in children. The visual system in particular is markedly affected, with an elevated prevalence of poor visual perceptual skills. Developmental problems involving the neocortex are likely to make a major contribution to some of these abnormalities. Neuronal selectivity to stimulus orientation, a functional property thought to be crucial for normal vision, may be especially vulnerable to alcohol exposure because it starts developing even before eye opening. To address this issue, we examined the effects of early alcohol exposure on development of cortical neuron orientation selectivity and organization of cortical orientation columns. Ferrets were exposed to ethanol starting at postnatal day (P) 10, when the functional properties and connectivity of neocortical neurons start to develop. Alcohol exposure ended at P30, just before eye opening at P32. Following a prolonged alcohol-free period (15-35 days), long-term effects of early alcohol exposure on cortical orientation selectivity were examined at P48-P65, when orientation selectivity in normal ferret cortex has reached a mature state. Optical imaging of intrinsic signals revealed decreased contrast of orientation maps in alcohol- but not saline-treated animals. Moreover, single-unit recordings revealed that early alcohol treatment weakened neuronal orientation selectivity while preserving robust visual responses. These findings indicate that alcohol exposure during a brief period of development disrupts cortical processing of sensory information at a later age and suggest a neurobiological substrate for some types of sensory deficits in FAS.  (+info)

Striatal inhibition of nociceptive responses evoked in trigeminal sensory neurons by tooth pulp stimulation. (6/35)

The noxious evoked response in trigeminal sensory neurons was studied to address the role of striatum in the control of nociceptive inputs. In urethane-anesthetized rats, the jaw opening reflex (JOR) was produced by suprathreshold stimulation of the tooth pulp and measured as electromyographic response in the digastric muscle, with simultaneous recording of noxious responses in single unit neurons of the spinal trigeminal nucleus pars caudalis (Sp5c). The microinjection of glutamate (80 etamol/0.5 microl) into striatal JOR inhibitory sites significantly decreased the A delta and C fiber-mediated-evoked response (53 +/- 4.2 and 43.6 +/- 6.4% of control value, P < 0.0001) in 92% (31/34) of nociceptive Sp5c neurons. The microinjection of the solvent was ineffective, as was microinjection of glutamate in sites out of the JOR inhibitory ones. In another series of experiments, simultaneous single unit recordings were performed in the motor trigeminal nucleus (Mo5) and the Sp5c nucleus. Microinjection of glutamate decreased the noxious-evoked response in Sp5c and Mo5 neurons in parallel with the JOR, without modifying spontaneous neuronal activity of trigeminal motoneurons (n = 8 pairs). These results indicate that the striatum could be involved in the modulation of nociceptive inputs and confirm the role of the basal ganglia in the processing of nociceptive information.  (+info)

Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. (7/35)

Here, we investigate the effects of endothelial nitric oxide synthase (eNOS) on angiogenesis, neurogenesis, neurotrophic factor expression, and neurological functional outcome after stroke. Wild-type and eNOS knock-out (eNOS-/-) mice were subjected to permanent occlusion of the right middle cerebral artery. eNOS-/- mice exhibited more severe neurological functional deficit after stroke than wild-type mice. Decreased subventricular zone (SVZ) progenitor cell proliferation and migration, measured using bromodeoxyuridine, Ki-67, nestin, and doublecortin immunostaining in the ischemic brain, and decreased angiogenesis, as demonstrated by reduced endothelial cell proliferation, vessel perimeter, and vascular density in the ischemic border, were evident in eNOS-/- mice compared with wild-type mice. eNOS-deficient mice also exhibited a reduced response to vascular endothelial growth factor (VEGF)-induced angiogenesis in a corneal assay. ELISAs showed that eNOS-/- mice have decreased brain-derived neurotrophic factor (BDNF) expression but not VEGF and basic fibroblast growth factor in the ischemic brain compared with wild-type mice. In addition, cultured SVZ neurosphere formation, proliferation, telomerase activity, and neurite outgrowth but not cell viability from eNOS-/- mice were significantly reduced compared with wild-type mice. BDNF treatment of SVZ cells derived from eNOS-/- mice restored the decreased neurosphere formation, proliferation, neurite outgrowth, and telomerase activity in cultured eNOS(-/-) SVZ neurospheres. SVZ explant cell migration also was significantly decreased in eNOS-/- mice compared with wild-type mice. These data indicate that eNOS is not only a downstream mediator for VEGF and angiogenesis but also regulates BDNF expression in the ischemic brain and influences progenitor cell proliferation, neuronal migration, and neurite outgrowth and affects functional recovery after stroke.  (+info)

Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. (8/35)

While Pavlovian and operant conditioning influence drug-seeking behavior, the role of rapid dopamine signaling in modulating these processes is unknown. During self-administration of cocaine, two dopaminergic signals, measured with 100 ms resolution, occurred immediately before and after the lever press (termed pre- and post-response dopamine transients). Extinction of self-administration revealed that these two signals were functionally distinct. Pre-response transients, which could reflect the motivation to obtain the drug, did not decline during extinction. Remarkably, post-response dopamine transients attenuated as extinction progressed, suggesting that they encode the learned association between environmental cues and cocaine. A third type of dopamine transient, not time locked to overt stimuli, decreased in frequency during extinction and correlated with calculated cocaine concentrations. These results show that dopamine release transients involved in different aspects of cocaine self-administration are highly plastic--differentially governed by motivation, learned associations linked with environmental stimuli, and the pharmacological actions of cocaine.  (+info)

Oxepins are organic compounds that contain a seven-membered ring with one oxygen atom and six carbon atoms. The structure of an oxepin is similar to that of benzene, but with one methine group (=CH−) replaced by an oxygen atom. This gives the oxepin ring a unique combination of aromaticity and reactivity, which makes it a subject of interest in organic chemistry and medicinal chemistry research.

Oxepins are relatively rare in nature, and they are not typically found in living organisms. However, some synthetic drugs contain an oxepin ring structure, and these compounds have been studied for their potential therapeutic uses. For example, some oxepin-containing drugs have been shown to have anti-inflammatory, antiviral, and antitumor properties.

It's worth noting that the term "oxepins" can also refer to a broader class of compounds that contain a seven-membered ring with one oxygen atom and any number of carbon atoms. However, in medical and pharmaceutical contexts, the term is most commonly used to refer specifically to the class of compounds described above.

A related dimethyl derivative exists mainly as the oxepin isomer, an orange liquid. Oxepin is an intermediate in the oxidation ... Wikimedia Commons has media related to Oxepin. E. Vogel; H. Günther (1967). "Benzene Oxide-Oxepin Valence Tautomerism". ... Oxepin is an oxygen-containing heterocycle consisting of a seven-membered ring with three double bonds. The parent C6H6O exists ... The oxepin-benzene oxide equilibrium is affected by the ring substituents. ...
... (EC 3.7.1.16, paaZ (gene)) is an enzyme with systematic name 2-oxepin-2(3H)-ylideneacetyl-CoA hydrolyase. ... Oxepin-CoA+hydrolase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 3.7.1). ... This enzyme catalyses the following chemical reaction 2-oxepin-2(3H)-ylideneacetyl-CoA + H2O ⇌ {\displaystyle \ ...
A pair of valence tautomers with formula C6H6O are benzene oxide and oxepin. Other examples of this type of tautomerism can be ... "Benzene Oxide-Oxepin Valence Tautomerism". Angewandte Chemie International Edition in English. 6 (5): 385-401. doi:10.1002/anie ...
Benzene oxide (C6H6O) exists as an equilibrium mixture with the seven-membered ring oxepin, which has three double bonds. They ... Vogel E, Günther H (1967). "Benzene Oxide-Oxepin Valence Tautomerism". Angewandte Chemie International Edition in English. 6 (5 ...
Chem., 1986, 51 (15), pp 2895-2898 doi:10.1021/jo00365a007 E. Vogel, H. Günther (1967). "Benzene Oxide-Oxepin Valence ...
Oxepin Ring Systems Containing Two Rings". Seven-Membered Heterocyclic Compounds Containing Oxygen and Sulfur. The Chemistry of ... ISBN 0-471-38210-8. Dimroth, K.; Pohl, G.; Follmann, H. (1966). "Die Synthese von Derivaten des 3-Oxepins und des Furans durch ... Photorearrangement of 1,4-epoxy-1,4-dihydronaphthalene to benz[f]oxepin". J. Am. Chem. Soc. 91 (2): 446-449. doi:10.1021/ ... oxygen-containing seven-membered heterocyclic oxepin. The first synthesis was described by Karl Dimroth and coworkers in 1961. ...
Azepane Benzazepines Diazepine Oxepin Borepin Smith, Jason A.; Molesworth, Peter P.; Hyland, Christopher J. T.; Ryan, John H. ( ...
Benzene oxide exists in equilibrium with the oxepin isomer. Ethylene oxide is widely used to generate detergents and ...
... , or dibenz[b,e]oxepin, is a tricyclic compound. It is the parent structure of certain drugs such as the tricyclic ...
Azepine Benzazepines Diazepine Oxepin Borepin CR gas (dibenzoxazepine) Katritzky, A. R.; Ramsden, C. A.; Scriven, E. F. V.; ...
Dimroth, K.; Pohl, G.; Follmann, H. (1966). "Die Synthese von Derivaten des 3-Oxepins und des Furans durch eine zweifache ...
... is an oxygen-containing bicyclic molecule consisting of an oxepin ring and a benzene ring. There are three isomers, ... varying in where the oxygen is positioned in the oxepin heterocycle relative where the benzene is fused to it. 1-Benzoxepin, ...
... converting benzene to oxepin (benzene oxide), phenol to hydroquinone, and hydroquinone to both benzenetriol and catechol. ...
Chem.; 1997; 62(12) pp 4162-4163; doi:10.1021/jo962267f Step one in this reaction between oxepin (one of the possible tautomers ...
... for the synthesis of oxepins from furans (known as Prinzbach-Tochtermann sequence). Tochtermann was born in Pforzheim. From ...
... oxepins MeSH D02.355.291.852.500 - doxepin MeSH D02.355.291.866 - oxocins MeSH D02.355.417.332 - ether, ethyl MeSH D02.355. ...
The chemical name of doxepin is (E/Z)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine and its free base form ...
Azonine Furan Cyclononatetraene Oxepin (2Z,4Z,6Z,8Z)-Thionine 12.27 Nine-Membered Rings, D. O. Tymoshenko v t e (Articles ...
2-oxepin-2(3H)-ylideneacetyl-CoA The enzyme catalyses the reversible isomerization of 2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA ...
The molecular formula C6H6O (molar mass: 94.11 g/mol, exact mass: 94.0419 u) may refer to: Oxanorbornadiene (OND) Oxepin Phenol ...
... may refer to: 3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde dehydrogenase, an enzyme Oxepin-CoA hydrolase, an enzyme ...
... oxepin-CoA hydrolase EC 3.7.1.17: 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase EC 3.7.1.18: 6 ... oxepin-CoA hydrolase * EC 3.3.2.13: chorismatase * EC 3.3.2.14: 2,4-dinitroanisole O-demethylase * EC 3.3.2.15: trans-2,3- ...
... oxepin-CoA hydrolase. Ferrández A, Miñambres B, García B, Olivera ER, Luengo JM, García JL, Díaz E (October 1998). "Catabolism ...
... oxepin-2(4H)-ylidene)acetaldehyde. The molecular formulas of each derivative were determined via high-resolution electrospray ...
A related dimethyl derivative exists mainly as the oxepin isomer, an orange liquid. Oxepin is an intermediate in the oxidation ... Wikimedia Commons has media related to Oxepin. E. Vogel; H. Günther (1967). "Benzene Oxide-Oxepin Valence Tautomerism". ... Oxepin is an oxygen-containing heterocycle consisting of a seven-membered ring with three double bonds. The parent C6H6O exists ... The oxepin-benzene oxide equilibrium is affected by the ring substituents. ...
Hi! Can I get a quote for a GreenScreen Assessment of Piperazine, 1-(10,11-dihydro-8-methyldibenz(b,f)oxepin-10-yl)-4-ethyl-, ... Share Piperazine, 1-(10,11-dihydro-8-methyldibenz(b,f)oxepin-10-yl)-4-ethyl-, maleate (1:1). × ... Piperazine, 1-(10,11-dihydro-8-methyldibenz(b,f)oxepin-10-yl)-4-ethyl-, maleate (1:1). ... Profile for "Piperazine, 1-(10,11-dihydro-8-methyldibenz(b,f)oxepin-10-yl)-4-ethyl-, maleate (1:1)" on Pharos: https:// ...
"Oxepins" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject Headings) ... This graph shows the total number of publications written about "Oxepins" by people in this website by year, and whether " ... Below are the most recent publications written about "Oxepins" by people in Profiles. ...
... oxepin-11-one. Acta Crystallographica Section E, 66 (1). O159-O160. ISSN 1600-5368 ...
EAWAG-BBD reactions whose substrate is 2-oxepin-2(3H)-ylideneacetyl-CoA *2-oxepin-2(3H)-ylideneacetyl-CoA -----, 3-Oxo-5,6- ... EAWAG-BBD reactions whose product is 2-oxepin-2(3H)-ylideneacetyl-CoA *1,2-Epoxyphenylacetyl-CoA -----, 2-oxepin-2(3H)- ... 2-oxepin-2(3H)-ylideneacetyl-CoA. *Formula: C29H38N7O18P3S4- *MW: 897.64. *SMILES String: CC(C)(COP([O-])(=O)OP([O-])(=O)OCC1OC ...
Dive into the research topics of Synthesis and antimicrobial evaluation of dibenzo[b,e]oxepin-11(6H)-one O-benzoyloxime ... Synthesis and antimicrobial evaluation of dibenzo[b,e]oxepin-11(6H)-one O-benzoyloxime derivatives. ...
Other names: 1-Propanamine, 3-dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-; Dibenz(b,e)oxepin-δ11(6H),γ-propylamine, N,N- ... dimethyl-; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz(b,e)oxipin; 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1- ... propanamine; NSC 108160; Doxepine; N,N-Dimethyldibenz(b,e)oxepin-δ11(6H),γ-propylamine ...
2,9,10-Trimeth-oxy-dibenzo[b,d]oxepin-7(6H)-one. Hou YJ, Song SL, Chu WY, Sun ZZ. Hou YJ, et al. Among authors: sun zz. Acta ...
1-(3,9-Dihydroxy-1,3-dihydrobenzo[c]oxepin-3-yl)ethanone, (rac)-. 0. ... 1-(3,9-Dihydroxy-1,3-dihydrobenzo[c]oxepin-3-yl)ethanone, (rac)-. 0. ...
Arene Oxides-Oxepins. Donald M. Jerina,* Haruhiko Yagi, and John W. Daly. ...
TY - JOUR. T1 - Fine-tuning of biaryl dihedral angles: Structural characterization of five homologous three-atom bridged biphenyls by X-ray crystallography. AU - Edwards, David J.. AU - Pritchard, Robin G.. AU - Wallace, Timothy W.. PY - 2005/6. Y1 - 2005/6. N2 - The homologous series of three-atom bridged biaryls comprising 5,7-dihydro-1 ,2,3,9,10,11-hexamethoxydibenzo-[c,e]oxepine, 6,7-dihydro-1,2,3,9, 10,11-hexamethoxy-6-methyl-5H-dibenzo[c,e]azepinium chloride, 5,7-dihydro-1,2,3,9,10,11-hexamethoxydibenzo[c,e]thiepine, and the 6-oxide and 6,6-dioxide derivatives of the latter have been characterized by X-ray crystal structure analysis. Within this series the endocyclic and exocyclic biaryl dihedral angles vary over 10° ranges, reflecting the changing balance of intramolecular (steric, geometric) and intermolecular (crystal packing) forces, the former being potential control elements for fine-tuning the helicity of the biaryl system. © 2005 International Union of Crystallography Printed in ...
The chemical name for olopatadine hydrochloride is (Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenz [b,e]oxepin-2- ...
Derivatives of 10-piperazino-10,11-dihydrodibenz[b,f]oxepin. 1969, Vol. 34, Issue 8, pp. 2258-2277 [Abstract] ... Zwei neue 6,11-Dihydrodibenz[b,e]oxepin-Derivate. 1967, Vol. 32, Issue 9, pp. 3448-3451 [Abstract] ...
Derivatives of 10-piperazino-10,11-dihydrodibenz[b,f]oxepin. 1969, Vol. 34, Issue 8, pp. 2258-2277 [Abstract] ... Zwei neue 6,11-Dihydrodibenz[b,e]oxepin-Derivate. 1967, Vol. 32, Issue 9, pp. 3448-3451 [Abstract] ...
Ring 1,2-epoxyphenylacetyl-CoA isomerase (oxepin-CoA forming). Model: iECSE_1348 ... Ring 1,2-epoxyphenylacetyl-CoA isomerase (oxepin-CoA forming). ...
Oxepins Preferred Term Term UI T029820. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1968). ... Oxepin Registry Number. 0. Public MeSH Note. 68. History Note. 68. Date Established. 1968/01/01. Date of Entry. 1999/01/01. ... Oxepins Preferred Concept UI. M0015643. Registry Number. 0. Scope Note. Compounds based on a 7-membered heterocyclic ring ... Oxepin Term UI T475058. Date12/27/2001. LexicalTag NON. ThesaurusID NLM (2003). ...
Oxepin 150mg Tablet 10S. ₹65.00. Add to cart. Estimated delivery date 2023/12/16 ...
BENZO[E]NAPHTHO[2,3:5,6]FLUORENO[1,9A-B]OXEPIN- 5,10,19(15H)-TRIONE,5C,8,8A,16-TETRAHYDRO-1,4,- 8,11,15,18-HEXAHYDROXY-13- ... Benzo[e]naphtho[2,3:5,6]fluoreno[1,9a-b]oxepin-5,10,19(15H)-trione,5c,8,8a,16-tetrahydro-1,8,11,15,18-pentahydroxy-13-methyl ... Synonyms: UNII-88B20HYO95, 88B20HYO95, Rubellin B, Rubellin B, (+)-, Benzo(E)naphtho(2,3:5,6)fluoreno(1,9a-b)oxepin-5,10,19( ... Synonyms: UNII-7UA9EUR7J9, 7UA9EUR7J9, Rubellin A, Rubellin A, (+)-, Benzo(E)naphtho(2,3:5,6)fluoreno(1,9a-b)oxepin-5,10,19( ...
GC-MS analysis yielded six compounds viz., 9,9 trimethyloctahydrbenzo(d) cycloprop(c) oxepin-2,4-dione (1), 3-Buten-2-one,3- ...
3-(Dibenzo[b,e]oxepin-11(6H)yl)-N,N-dimethylpropan-1-amine Hydrochloride (TRC-D417663-10MG). Read more ... Dibenz[b,e]oxepin-11(6H)-one (TRC-D416925-1G). Read more ...
The purpose of this work is to synthesize annulene-o,m,o,m-oxacalix[4]arene hybrid molecules which exist in a tweezer-like conformation with cofacial annulenes due to the chalice-like nature of oxacalixarenes. These hybrid molecules will provide insight on interactions between cofacial aromatic and antiaromatic annulenes. To develop the methodology for the synthesis of these annulene-oxacalixarene hybrids, a series p-substituted phenylethynyl-o,m,o,m-oxacalix[4]arenes are being prepared. This poster will discuss two different approaches to the synthesis of these compounds. In the first method, the Sonogashira coupling precedes oxacalixarene formation. In the second approach, a tetraiodo oxacalixarene undergoes Sonogashira coupling with appropriate phenylacetylenes.
Email me at this address if my answer is selected or commented on:Email me if my answer is selected or commented on ...
Glossary: oxepin-CoA = 2-oxepin-2(3H)-ylideneacetyl-CoA. Other name(s): paaZ (gene name). Systematic name: 2-oxepin-2(3H)- ... Accepted name: oxepin-CoA hydrolase. Reaction: 2-oxepin-2(3H)-ylideneacetyl-CoA + H2O = 3-oxo-5,6-dehydrosuberyl-CoA ... Combined the two activities result in a two-step conversion of oxepin-CoA to 3-oxo-5,6-dehydrosuberyl-CoA, part of an aerobic ...
11-oxo-6,11-dihydro-dibenzo[b,e]oxepin-2-yl)-acetic acid butyl ester. ...
Oxepin capsule 6/25 mg 14s ₨ 396.70. You will pay -139.7 more. ...
fused oxepin-CoA hydrolase/3-oxo-5,6-dehydrosuberyl-CoA semialdehyde dehydrogenase. ...
CAS No:1229-29-4,,Chemical Formula:C19H22ClNO,,(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine ... CAS No:3607-18-9,,Chemical Formula:C19H21NO ,,(Z)-3-(dibenzo[b,e]oxepin-11(6H)-y…… ... CAS No:4504-87-4,,Chemical Formula:C14H10O2,,dibenzo[b,e]oxepin-11(6H)-one (doxe…… ... CAS No:4504-96-5,,Chemical Formula:C18H20ClNO,,(E)-3-(dibenzo[b,e]oxepin-11(6H)-…… ...

No FAQ available that match "oxepins"

No images available that match "oxepins"